Posted by Chairman_MAO on April 28, 2005, at 16:51:00
In reply to Strattera, posted by Maxime on April 28, 2005, at 16:17:15
Strattera was an orphaned antidepressant floating around Lilly's lab. It's has one strength: it is not a "controlled substance", and so they can market it aggressively using that angle. Pretty stupid if you ask me, since what makes something a controlled substance is merely how many people wish to take it. So we should buy Strattera because no one likes taking it? Sounds great!
I also love how Lilly calls it "the first nonstimulant treatment for ADHD". What about TCAs? Or reboxetine. Oh, wait, they blocked FDA approval of reboxetine. Or selegiline? Man, I shouldn't get started with this, I'll never stop.
Honestly, I think that crap is toxic. Lilly doesn't have to publish any studies it doesn't want to. They put a black-box warning about liver damage on Strattera despite only two officially recognized cases of atomoxetine-induced liver damage. For some reason, I think there's something they're not telling us.
Listen to your body. I never felt the way you are describing when I started Parnate, buprenorphine, or any other medication that ever did any good for me.
poster:Chairman_MAO
thread:491037
URL: http://www.dr-bob.org/babble/20050428/msgs/491067.html